4//SEC Filing
Cole Hugh M 4
Accession 0001640455-21-000021
CIK 0001640455other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:36 PM ET
Size
12.3 KB
Accession
0001640455-21-000021
Insider Transaction Report
Form 4
Cole Hugh M
Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-01-22−5,000→ 55,000 totalExercise: $6.55Exp: 2030-02-03→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2021-01-22$6.55/sh+5,000$32,750→ 65,189 total - Sale
Common Stock
2021-01-22$11.95/sh−18,000$215,100→ 47,189 total - Exercise/Conversion
Common Stock
2021-01-22$4.40/sh+5,000$22,000→ 60,189 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-22−5,000→ 39,500 totalExercise: $4.40Exp: 2029-02-01→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2020. The Reporting Person exercised no discretion with respect to these transactions.
- [F2]Represents the weighted average share price of an aggregate total of 18,000 shares sold in the price range of $11.66 to $12.24 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The option will vest quarterly in 16 equal installments following January 1, 2019.
- [F4]The option will vest quarterly in 16 equal installments following January 1, 2020.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001604646
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:36 PM ET
- Size
- 12.3 KB